Apoptos
Latest round
- Series A
Last raised
- May 2008
Total raised
- $28M
Investors
- 4
About Apoptos
Apoptos Inc. is a biopharmaceutical company, is focused on developing novel small molecule drug therapies that directly induce tumor cell apoptosis.
Who invested in Apoptos
4 investors across 1 round
See all investors in Apoptos
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 6, 2008
Amount
$28M
Investors
Questions about Apoptos
Who invested in Apoptos?
Apoptos has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Apoptos raised?
Apoptos has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Apoptos last raise money?
Apoptos's most recent round on record is a Series A, in May 2008.
What does Apoptos do?
Apoptos is a biotechnology company.
Where is Apoptos headquartered?
Apoptos is headquartered in San Diego, US.
Which VCs invest in companies like Apoptos?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Apoptos's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Apoptos? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.